XORTX Therapeutics, Inc. (XRTX)
0.9702
-0.04
(-3.94%)
USD |
NASDAQ |
Oct 20, 16:00
1.05
+0.08
(+8.23%)
After-Hours: 20:00
XORTX Therapeutics Net Income (Quarterly) : -1.691M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.691M |
| March 31, 2026 | -0.8085M |
| December 31, 2025 | -0.5905M |
| September 30, 2025 | -0.6495M |
| June 30, 2025 | -0.7177M |
| March 31, 2025 | -0.6987M |
| December 31, 2024 | 0.1225M |
| September 30, 2024 | -0.587M |
| June 30, 2024 | 0.1701M |
| March 31, 2024 | -3.019M |
| December 31, 2023 | 2.699M |
| September 30, 2023 | -1.333M |
| June 30, 2023 | -1.692M |
| March 31, 2023 | -1.832M |
| December 31, 2022 | -2.150M |
| September 30, 2022 | -1.196M |
| June 30, 2022 | -1.239M |
| Date | Value |
|---|---|
| March 31, 2022 | -2.703M |
| December 31, 2021 | 7.214M |
| September 30, 2021 | -6.630M |
| June 30, 2021 | -0.1779M |
| March 31, 2021 | -1.716M |
| December 31, 2020 | -0.3474M |
| September 30, 2020 | -0.3189M |
| June 30, 2020 | -0.2698M |
| March 31, 2020 | -0.0247M |
| December 31, 2019 | -0.1435M |
| September 30, 2019 | -0.0998M |
| June 30, 2019 | -0.1162M |
| March 31, 2019 | -0.115M |
| December 31, 2018 | -0.1117M |
| September 30, 2018 | -0.2348M |
| June 30, 2018 | -0.2129M |
| March 31, 2018 | -2.409M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | -1.993M |
| InMed Pharmaceuticals, Inc. | -4.843M |
| Target Group, Inc. (Canada) | -0.2398M |
| NervGen Pharma Corp. | 7.803M |
| Milestone Pharmaceuticals, Inc. | -28.61M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.691M |
| EPS Diluted (Quarterly) | -1.045 |
| Enterprise Value | 0.7539M |
| Earnings Yield | -282.9% |
| Normalized Earnings Yield | -293.89 |